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Abstract In the present study the susceptibility of different 
subsets of immature rat thymocytes to undergo apoptosis was 
examined. Unfractionated rat thymocytes were negatively 
enriched into immature double positive (CD4+CD8+), immature 
single positive (CD4 CD8+CD3 ) and triple negative 
(CD4 CD8 CD3 ) thymocytes. These enriched subsets of 
immature thymocytes were then exposed to various apoptotic 
stimuli such as dexamethasone, etoposide and thapsigargin which 
readily induced apoptosis in unfractionated rat thymocytes. We 
found that the double positive thymocytes and their precursor 
cells, i.e. the single positive immature thymocytes, were equally 
sensitive to apoptosis after treatment with the apoptotic stimuli. 
In sharp contrast, the early migrants or precursor-containing 
thymocytes which are triple negative have a lower spontaneous 
apoptosis rate and were relatively resistant to all the apoptotic 
stimuli. These findings showed a breakpoint in thymocyte 
sensitivity to apoptosis which occurs after the onset of CD8 
expression, suggesting that susceptibility of thymocytes to 
apoptosis is developmentally regulated. 
© 1997 Federation of European Biochemical Societies. 
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1. Introduction 
Apoptosis is a form of controlled cell death that is distinct 
from necrosis. It plays an important role in diverse biological 
processes and occurs in most tissues at some stage during 
development [1,2]. Distinct morphological and biochemical 
changes take place during apoptosis which lead to the con-
trolled destruction of the cell. These changes include cell 
shrinkage, plasma and nuclear membrane blebbing, nuclear 
condensation, and cleavage of chromatin into both high mo-
lecular weight (HMW) and oligonucleosomal-length DNA 
fragments presumably as a result of endonuclease activity 
[3-5]. The cell eventually disintegrates into small apoptotic 
bodies, which are recognised and engulfed by neighbouring 
cells or macrophages [6]. 
A model system that has come to the forefront of these 
studies in the last decade is the use of isolated thymocytes 
in vitro. It is well established that a variety of agents including 
glucocorticoids, compounds reactive with DNA topoisomer-
ase II, and intracellular Ca2+ elevating agents, induce exten-
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sive apoptosis in isolated thymocytes [7-9]. However, isolated 
thymocytes constitute a very heterogeneous population, con-
sisting of at least five different subsets of thymocytes at differ-
ent stages of development, which can be distinguished by the 
expression of certain cell surface antigens [10,11]. The early 
migrants from the bone marrow or progenitor T cells are 
essentially CD4 CD8 CD3 or triple negative (TN) cells. 
This population expands into the CD8+CD3 - single positive 
(SP) immature thymocytes, which are also precursor cells for 
the CD4+CD8+ double positive (DP) thymocytes [12,13]. 
More than 80% of the cells in unseparated thymocytes express 
the DP phenotype [14]. The other two subsets are the mature 
T cells which have survived the clonal deletion, i.e. the 
CD4+CD8CD3+ SP and CD8+CD4CD3+ SP mature thy-
mocytes [10,11,14]. 
Various reports have suggested that most of the cells dying 
of apoptosis in unseparated thymocytes after glucocorticoid 
treatment or an elevation of cytosolic free calcium concentra-
tion were of the CD4+CD8+ DP phenotype [15,16]. The sup-
porting evidence for this came from studies using flow cytom-
etry and phenotyping the surviving cells after induction of 
apoptosis. However, phenotyping thymocytes after induction 
of apoptosis may not provide a clear indication of the pop-
ulation of cells surviving or undergoing apoptosis as some cell 
surface antigens, for instance CD4 and CD8, are down-regu-
lated in thymocytes undergoing apoptosis [16]. Furthermore, 
one of the earliest characteristic changes in apoptotic cells is 
the profound effect on plasma membrane lipid packing, which 
could affect the presentation of various surface antigens [17]. 
In the present study, the susceptibility of different subsets of 
immature thymocytes to undergo apoptosis was examined in 
greater detail. The different subsets of immature thymocytes, 
i.e. DP, CD8+ SP and TN were negatively enriched from 
unfractionated thymocytes and their propensity to undergo 
apoptosis examined using various apoptosis-inducing agents. 
Our present findings indicate that TN cells are relatively re-
sistant to the induction of apoptosis by various stimuli, where-
as both CD8+ SP and DP cells are equally sensitive to apop-
tosis induced by these agents. 
2. Materials and methods 
2.1. Animals 
Male Fischer 344 rats 4-5 weeks old, bred at the Medical Research 
Council Toxicology Unit (Leicester University, UK) under pathogen-
free conditions were used. 
2.2. Reagents 
The hybridomas producing the rat monoclonal antibodies (mAb) 
OX-8, anti-CD8 [14], OX-44, anti-CD53 [18], W3-25, anti-CD4 [14], 
OX-19, anti-CD5 [19] were obtained from the European Collection of 
Animal Cell Cultures (Salisbury, UK), and used as culture superna-
tants. The hybridoma producing anti-T cell receptor (TCR), R73 (pan 
aß) was kindly provided by Dr. T. Hunig (Würzburg, Germany) [20]. 
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Purified anti-CD4 coupled to FITC, biotin-labelled anti-CD8 and 
phycoerythrin (PE)-coupled streptavidin were obtained from Serotec 
(UK). Dexamethasone (Dex) and etoposide (VP-16) (a DNA topo-
isomerase II inhibitor) were obtained from Sigma Chemical Co. (UK), 
and thapsigargin was from Gibco BRL (UK). Goat anti-mouse IgG 
(GAMIgG)-coated BioMag beads were from Advance Magnetics 
(UK) and GAMIgG-coated Dynal beads were from Dynal (Norway). 
2.3. Thymocyte isolation and subset enrichment 
Thymocytes were isolated as previously described [8] and «sus-
pended in RPMI 1640 supplemented with 10% FCS. AU the subsets 
of immature thymocytes, C D 4 C D 8 C D 3 ~ TN, CD4CD8 + CD3~ 
SP and CD4+CD8+ DP cells, were enriched by negative selection. 
Total thymocytes were incubated with different cocktails of saturating 
mAb-containing hybridoma culture supernatants, OK-8, W3/25 and 
R73 (TN cells), W3/25, OX-44 and R73 (CD8+ SP cells) or OX-44 
(DP cells) for 30 min on ice. The cells were washed twice with ice-cold 
PBS and then incubated with GAMIg-coated Biomag beads at 10:1 
beads to cell ratio. The cell suspensions were incubated on ice for 30 
min with gentle mixing every 5 min. Magnetic beads and adhering 
cells were removed using a magnetic particle separator (Dynal MPC-
6). The procedure was repeated twice, with Biomag beads at 5:1 bead 
to cell ratio followed by GAMIgG-coated Dynal beads at 2:1 beads 
to cell ratio. The cells recovered were used as TN, CD8+ SP and DP 
cells in experiments. 
2.4. Cell culture 
For in vitro culture and treatment of thymocytes, 1.25 X 106 cells/ml 
were cultured in 2 ml RPMI 1640 medium supplemented with 10% 
FCS, in 24-well plates with the agents of interest in a humidified 
incubator with 5% CO2 in air. After 4 h, aliquots of 1 X 106 cells 
from each treatment were taken for HMW as well as nucleosomal 
DNA analysis, and 0.5 X 106 cells taken for quantification of apopto-
sis using flow cytometry. 
2.5. Flow cytometric analysis 
Flow cytometric analysis was used to (a) phenotype the cell surface 
markers on the enriched thymocyte subsets and (b) quantitate the 
percentage of cells undergoing apoptosis in thymocytes after treat-
ment with various apoptosis-inducing agents. In phenotyping analysis, 
all the antibodies used were at saturating concentrations. For two-
colour immunofluorescence labelling, 1 X 106 cells in 50 ul PBS con-
taining 0.2% FCS and 0.2% sodium azide were sequentially exposed to 
(a) biotin-conjugated mAb to the first marker and FITC-conjugated 
mAb to the second marker; (b) streptavidin-conjugated PE. Analysis 
was performed on a FACScan flow cytometer (Becton Dickinson). 
Light scatter gates were set to include all viable nucleated cells. Sam-
ples were analysed using the LYSIS II software and are displayed as 
dotplots. Populations of cells expressing markers were calculated from 
quadrants set using the appropriate negative controls. 
To detect apoptotic thymocytes, the cells were prepared as previ-
ously described [21] before analysis using a Vantage flow cytometer 
(Becton Dickinson) equipped with an argon laser tuned to the blue 
line (488 nm) and a krypton laser tuned to 352 nm. In brief, after 
incubation the cells were centrifuged to remove the medium. The cell 
pellets were dispersed gently, resuspended in 1 ml RPMI medium and 
incubated with the fluorescent dye, Hoechst 33342, at 1.5 |xg/ml for 10 
min at 37°C. The cells were centrifuged to remove the excess dye in 
the PBS and the pellet was resuspended in PBS with 0.005 u.g/ml 
propidium iodide. The stained cells were stored on ice until analysis. 
2.6. Analysis of nucleosomal DNA fragments and the formation of 
HMW DNA fragments 
The analysis of nucleosomal DNA fragments was essentially that 
described by Sorenson et al. [22]. In brief, after incubation, an aliquot 
of thymocyte suspension from each treatment containing 1 X 106 cells 
was dispensed in Eppendorf tubes. The cells were centrifuged at 
200 X g for 5 min and the medium removed. The cell pellet was re-
suspended in 15 |il water followed by 5 (xl RNAse (stock, 50 mg/ml) 
Fig. 1. Phenotypes of the enriched subsets of immature thymocytes. Unseparated thymocytes were incubated with various cocktails of mAbs 
and then positively depleted using GAM magnetic beads. The enriched negative selected DP, SP, TN and unfractionated thymocytes were phe-
notyped for CD4 and CD8 antigens using a FAScan flow cytometer as outlined in Section 2. The numbers represent the percentage of cells in 
each quadrant. 
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and 5 ul loading buffer. The cell mixture was mixed thoroughly before 
10 ul from each sample was loaded into each well of a 1.8% agarose 
gel with a precast digestion gel. The gel was electrophoresed for 1 h at 
20 V followed by 3 h at 90 V before being visualised under UV 
illumination. The formation of HMW DNA fragments was analysed 
using field inversion gel electrophoresis as previously reported [5]. In 
brief, after incubation 1 X 106 cells from each treatment were centri-
fuged and the medium was removed. The cell pellets were resuspended 
in soft melting agarose and pipetted into the wells of a plug mould. 
The agarose plugs were digested for 48 h at 50°C with pronase (1 mg/ 
ml final concentration) before being inserted into the wells of a 1% 
agarose gel. The HMW DNA fragments were electrophoresed using 
conditions previously described [5], and visualised using UV illumina-
tion. 
3. Results and discussion 
In the present investigation, the susceptibility of different 
subsets of immature thymocytes to undergo apoptosis after 
treatment with various apoptotic stimuli was examined. To 
obtain relatively pure populations of different subsets of im-
mature thymocytes, unfractionated thymocytes were nega-
tively selected by the positive depletion of unwanted cells on 
the basis of their cell surface markers which are expressed 
differentially during thymocyte development. This procedure 
avoided the possible activation of cells through various cell 
surface antigens, which may affect their sensitivity to apopto-
sis if the cells had been purified by positive selection. Imma-
ture DP thymocytes, which represent ~ 85% of unseparated 
thymocytes, do not express the cell surface antigen, OX-44 
(rat homologue of CD53 [18]) which is present in mature SP 
and immature DN thymocytes. Accordingly, total thymocytes 
were depleted of CD53+ cells by magnetic cell sorting with 
anti-CD53 mAbs. This procedure routinely yielded DP cells of 
greater than 90% purity (Fig. 1). Immature CD8+ SP thymo-
cytes, which are the precursors for DP cells, represent only 
~ 2 % of the total unseparated thymocytes [14]. Similar to DP 
cells, CD8+ SP cells do not express the CD53 cell surface 
antigen [13], and were enriched by depleting cells expressing 
CD53, CD4 and TCR cell surface antigens using magnetic cell 
sorting with anti-CD53, anti-CD4 and anti-TCR mAbs. Rou-
tinely 85-90% CD8+ SP cells were obtained in this fashion, 
which represented a 40-fold enrichment (Fig. 1). Enrichment 
of TN rat T cell progenitor thymocytes was achieved by de-
pleting thymocytes expressing CD8, CD4 and TCR cell sur-
face antigens using magnetic cell sorting with anti-CD8, anti-
CD4 and anti-TCR mAbs. This procedure routinely yielded a 
cell population of ~ 9 5 % purity, which did not express CD4 
and CD8 antigens (Fig. 1). 
To determine the susceptibility of these subsets of immature 
thymocytes to apoptosis, negatively enriched TN, CD8+ SP 
and DP immature thymocytes were incubated with Dex (0.1 
uM), etoposide (10 uM) and thapsigargin (50 nM). These 
compounds have all been shown previously to induce exten-
sive apoptosis in unfractionated thymocyte populations [4,7-
9]. Apoptosis was determined using three different assays, i.e. 
a flow cytometry to quantitate apoptotic as well as viable cells 
[21], field inversion gel electrophoresis to detect the formation 
of HMW DNA fragments > 50 kb due to chromatin cleavage 
[5], and the standard agarose gel assay for separating nucleo-
somal-length DNA fragments < 50 kb. After 4 h incubation, 
cell viability in all the untreated control thymocyte subsets as 
well as unseparated thymocytes was 90-95% as determined by 
PI staining (Table 1). Cell viability in treated thymocytes var-
Table 1 
Apoptosis and viability of immature thymocytes in response to various apoptotic stimuli 
Subset Treatment Apoptosis (%) Viability (%) 
Unfractionated thymocytes -
Dex 
etoposide 
thapsigargin 
14.9 ±2.5 
39.8 ±4.3 
60.9 ±2.4 
43.2 ±12 
90.6 ±2.0 
89.2 ±1.5 
89.2 ±3.5 
85.6 ±3.5 
CD4+CD8+ DP thymocytes -
Dex 
etoposide 
thapsigargin 
11.4 ±0.6 
43.7 ±3.9 
61.2±1.1 
52.8 ±14 
95.4 ±1.0 
89.0 ±2.3 
89.4 ±1.4 
84.8 ±3.9 
CD4CD8+CD3" SP thymocytes -
Dex 
etoposide 
thapsigargin 
20.8 ±2.7 
48.7 ±3.0 
70.3 ±5.0 
56.9 ±7.7 
91.4±0.6 
89.2 ±1.2 
88.6 ±1.9 
87.4 ±2.8 
CD4-CD8~CD3- TN thymocytes -
Dex 
etoposide 
thapsigargin 
NA' 
NA 
NA 
NA 
93.3 ±0.2 
91.0±0.3 
87.8 ±1.4 
90.4 ±1.6 
Unfractionated and negatively enriched DP, SP and TN subsets of thymocytes (5 X106 cells/ml) were treated with various apoptotic stimuli for 3 h 
and the percent of cells undergoing apoptosis and cell viability were assayed using flow cytometry as outlined in Section 2. Data are the means 
±S.E.M. of 3-5 experiments. NA: not available. 
aMore than 50% of this subset of cells do not take up Hoechst 33342. 
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Fig. 2. Effect of various apoptotic stimuli on the formation of HMW DNA fragments in enriched subsets of immature thymocytes. The en-
riched subsets of immature DP, SP, TN and unfractionated thymocytes were treated with 0.1 uM Dex, 10 uM VP16 (etoposide) and 50 nM 
thapsigargin (Tg) for 4 h. Thereafter agarose plugs were prepared with these cells and the formation of HMW DNA fragments was analysed 
using FIGE as described in Section 2. 
ied between 85 and 91% (Table 1) and was not significantly 
different from control values. Treatment of unfractionated 
thymocytes with Dex, etoposide and thapsigargin resulted in 
39.8, 60.9 and 43.2% apoptotic cells, respectively, as compared 
to ~ 14.8% untreated cells (Table 1). As expected, a similar 
extent of apoptotic cells was observed with the enriched DP 
cell population after treatment with Dex, etoposide and thap-
sigargin (Table 1) confirming previous observations that the 
DP cells in unseparated thymocytes are highly sensitive to 
apoptosis [15,16]. Although the enriched CD8+ SP cells ap-
pear to have a higher percentage of cells undergoing apoptosis 
after exposure to Dex, etoposide and thapsigargin compared 
to the DP thymocytes (Table 1), its spontaneous apoptosis 
rate was also higher. With the enriched TN cells about 50% 
of this population of cells did not take up the Hoechst 33342 
dye, and therefore, the flow cytometric assay could not be 
used to quantify apoptosis in this subpopulation of cells. 
This finding indicated that under these conditions the Hoechst 
33342 DNA dye did not permeate all cells and therefore, 
caution must be exercised to carefully evaluate the permeabil-
ity of each cell type to the dye before using this method. 
The susceptibility of the enriched immature subsets of thy-
mocytes to undergo apoptosis after treatment with various 
apoptotic stimuli was further examined by the HMW and 
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Fig. 3. Formation of oligonucleosomal-length DNA fragments in different subsets of immature thymocytes after exposure to different apoptotic 
stimuli. The enriched subsets of immature DP, SP, TN and unfractionated thymocytes were treated with 0.1 uM Dex, 10 uM VP16 (etoposide) 
and 50 nM thapsigargin (Tg) for 4 h and the formation of oligonucleosomal-length DNA fragments was analysed using conventional gel elec-
trophoresis as described in Section 2. 
oligonucleosomal-length DNA fragments formed. As illus-
trated in Fig. 2, HMW DNA fragments of 50 kb were formed 
in control unfractionated thymocytes (lane 13) due to sponta-
neous apoptosis, which corresponded with a low level of 
DNA degraded to oligonucleosomal-length fragments (Fig. 
3, lane 13). Upon treatment with Dex, etoposide and thapsi-
gargin, an extensive level of HMW DNA fragments was 
formed and accumulated at around 50 kb (Fig. 2, lanes 14, 
15 and 16, respectively), which correlated with a similar in-
crease in the formation of oligonucleosomal-length fragments 
(Fig. 3, lanes 14, 15 and 16). Similar to unfractionated thy-
mocytes, the formation of 50 kb HMW DNA fragments in 
both DP as well as CD8+ SP thymocytes was extensive after 
apoptotic stimuli treatment (Fig. 2, lanes 1-4 for DP cells, and 
lanes 5-8 for CD8+ SP cells). As previously observed with 
unfractionated thymocytes, the degree of DNA degradation 
into oligonucleosomal-length DNA fragments in these cells 
(Fig. 3, lanes 1^1 for DP cells, and lanes 5-8 for CD8+ SP 
cells) correlated well with the formation of HMW DNA. With 
the TN cells only a small amount of HMW DNA fragments 
(Fig. 2, lane 9) was observed in the control cells, which was 
much lower than that seen with the DP, SP or unfractionated 
thymocytes. This indicated that the TN cells had a lower 
spontaneous apoptotic rate compared to the other immature 
subsets of thymocytes. Upon treatment with apoptotic stimuli 
only a small increased in the formation of 50 kb HMW DNA 
fragments (Fig. 2, lanes 10-12) was seen with the TN cells, 
suggesting that these cells were less sensitive to the apoptotic 
stimuli compared to the other immature thymocyte subsets. 
Etoposide, which caused extensive accumulation of 50 kb 
HMW DNA fragments in both the DP and CD8+ SP subsets, 
was only moderately effective in TN cells (Fig. 2, lane 11), 
whereas both Dex and thapsigargin had little effect. Similarly, 
a corresponding decrease in oligonucleosomal-length DNA 
was also observed in the TN cells after exposure to the apop-
totic stimuli (Fig. 3, lanes 10-12). Thus, TN cells were less 
susceptible to apoptosis after Dex, etoposide and thapsigar-
gin treatment compared to DP, CD8+ SP immature thymo-
cytes. 
These findings are in part compatible with the observations 
of Andjelic et al. [23] that in mice the TN cells are insensitive 
to calcium-mediated apoptosis. This resistance of TN cells 
was proposed to be related to a high level of expressed bcl-
2 mRNA [23]. Since over-expression of bcl-2 also blocks ster-
oid-induced apoptosis [24,25], it is possible that bcl-2 is re-
sponsible for the resistance to Dex- or etoposide-induced 
apoptosis in TN cells. Thymic regeneration studies in mice 
after in vivo steroid treatment suggest that a population of 
cells other than SP mature thymocytes is capable of regener-
ating thymocytes after thymic involution [26,27]. Because TN 
cells consist of early progenitor T cells or pro-thymocytes, it is 
likely that the steroid-insensitive population of cells in steroid-
treated mice are the TN cells. Our present results also indicate 
that beside the DP cells, the CD8+ SP thymocyte subset are 
also susceptible to apoptosis. It has been shown previously 
that the CD8+ SP subset is a transition population of cells 
from CD4 CD8 to CD4+CD8+, having no IL-2 receptors 
and expressing low or undetectable TCR [13,28]. This suggest 
that the CD8+ SP cells may be involved in positive selection 
in vivo, since the loss of IL-2 receptors and the beginning of 
TCR expression in TN cells marks the start of negative selec-
tion during thymocyte development [10,11]. Taken together, 
these findings suggest that the susceptibility of immature thy-
mocytes to apoptosis may be developmentally regulated and 
that the onset of antigen expression involved in thymic selec-
tion marks the breakpoint of this sensitivity. 
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